Cargando…
The role of delayed bone age in the evaluation of stature and bone health in glucocorticoid treated patients with Duchenne muscular dystrophy
BACKGROUND: Low bone mineral density and an increased risk of appendicular and vertebral fractures are well-established consequences of Duchenne muscular dystrophy (DMD) and the risk of fractures is exacerbated by long-term glucocorticoid treatment. Monitoring of endocrine and skeletal health and ti...
Autores principales: | Annexstad, E. J., Bollerslev, J., Westvik, J., Myhre, A. G., Godang, K., Holm, I., Rasmussen, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6927168/ https://www.ncbi.nlm.nih.gov/pubmed/31889957 http://dx.doi.org/10.1186/s13633-019-0070-0 |
Ejemplares similares
-
Growth Hormone Therapy for Children With Duchenne Muscular Dystrophy and Glucocorticoid Induced Short Stature
por: Lavi, Eran, et al.
Publicado: (2021) -
Skeletal disproportion in glucocorticoid-treated boys with Duchenne muscular dystrophy
por: Kao, Kung-Ting, et al.
Publicado: (2019) -
Optimizing Bone Health in Duchenne Muscular Dystrophy
por: Buckner, Jason L., et al.
Publicado: (2015) -
Delay in Diagnosis of Duchenne Muscular Dystrophy
por: Rao, Vamshi K., et al.
Publicado: (2015) -
Bone Mineral Density and Bone Metabolism in Patients with Duchenne Muscular Dystrophy
por: BARZEGAR, Mohammad, et al.
Publicado: (2018)